AAAAAA
Results:
1-10
|
Results: 10
Authors:
MANNERMAA A
HARTIKAINEN J
ARFFMAN A
PIRSKANEN M
RISTONMAA U
KATAJA V
KOSMA VM
ESKELINEN M
RYYNANEN M
Citation: A. Mannermaa et al., SCREENING FINNISH BREAST OVARIAN CANCER FAMILIES FOR SEQUENCE ALTERATIONS IN THE BRCA1 AND BRCA2 GENES/, European journal of human genetics, 6, 1998, pp. 4181-4181
Authors:
KESKIKURU R
JUKKOLA A
RISTELI J
RISTELI L
KATAJA V
Citation: R. Keskikuru et al., CARBOXYTERMINAL TELOPEPTIDE OF TYPE-I COLLAGEN (ICPT) - A POTENTIAL SERUM MARKER IN DIAGNOSIS OF ADVANCED BREAST-CANCER, European journal of cancer, 34, 1998, pp. 28-28
Authors:
ROMPPANEN J
KESKIKURU R
KATAJA V
ESKELINEN M
KOSMA VM
SAVOLAINEN K
UUSITUPA M
MONONEN I
Citation: J. Romppanen et al., SERUM PROSTATE-SPECIFIC ANTIGEN IN BENIGN AND MALIGNANT BREAST DISEASE, Clinical chemistry, 44, 1998, pp. 173-173
Authors:
ESKELINEN M
KATAJA V
HAMALAINEN E
KOSMA VM
PENTTILA I
ALHAVA E
Citation: M. Eskelinen et al., SERUM TUMOR-MARKERS CEA, AFP, CA 15-3, TPS AND NEU IN DIAGNOSIS OF BREAST-CANCER, Anticancer research, 17(2B), 1997, pp. 1231-1234
Authors:
KATAJA V
DEBRUIJN KM
Citation: V. Kataja et Km. Debruijn, HYPERSENSITIVITY REACTIONS ASSOCIATED WITH 5-HYDROXYTRYPTAMINE(3)-RECEPTOR ANTAGONISTS - A CLASS EFFECT, Lancet, 347(9001), 1996, pp. 584-585
Authors:
KATAJA V
YAP A
Citation: V. Kataja et A. Yap, COMBINATION OF CISPLATIN AND INTERFERON ALFA-2A (ROFERON-A) IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER (NSCLC) - AN OPEN PHASE-II MULTICENTER STUDY (VOL 31, PG 35, 1995), European journal of cancer, 31A(6), 1995, pp. 1028-1028
Authors:
KATAJA V
YAP A
Citation: V. Kataja et A. Yap, COMBINATION OF CISPLATIN AND INTERFERON-ALPHA-2A (ROFERON(R)-A) IN PATIENTS WITH NONSMALL CELL LUNG-CANCER (NSCLC) - AN OPEN PHASE-II MULTICENTER STUDY, European journal of cancer, 31A(1), 1995, pp. 35-40
Authors:
DALLEY D
LEVI J
BELL D
GREEN M
SHERMAN P
ZALCBERG J
ZIMET A
THOMSON D
WALPOLE E
ACKLAND S
STEWART J
SCHULLER J
FOGL U
WIRTH M
LUTZ D
SALOMON J
VANTRAPPEN G
VANCUTSEM E
LEPOUTRE L
DEFACQ L
BURY J
REGINSTER M
FROIMTCHUK M
DEOLIVEIRA MDLL
SCALETZKY A
KOCHA W
SKILLINGS J
WEINERMAN B
SHORE T
MAROUN J
CRIPPS C
GOEL R
BATIST G
BOOS G
GADEBERG C
KJAER M
BRUNSGAARD N
JAKOBSEN A
MEJLHOLM J
BERTELSEN K
MADSEN EL
JORGENSEN A
SANDBERG E
PYRHONEN S
ISOKANGAS OP
JOHANSSON R
KATAJA V
ROUGIER P
BECOUARN Y
BRUNET R
FRANCOIS E
NAMER M
SEITZ J
GIOVANNINI H
REBATTU P
MERROUCHE Y
LANKISCH P
HEISE J
MAY B
GREVING J
SODOMANN C
BERGERMANN H
MERTELSMANN R
SCHUPP M
PORZSOLT F
STEINACKER RM
CARTEI G
BAJETTA E
COLLEONI M
PANNUTI E
FOSSER V
BERG C
RAVN H
EGELI R
GUILLOU P
SOMERS S
CAREY P
PRIMROSE J
SELBY P
WARD U
BUDDE M
HOLDENER EE
MAN A
MASSIMINI G
SMITH H
LUYKX R
BLAES C
YAP AKL
HOLMSTROM S
COCKEY L
Citation: D. Dalley et al., PHASE-III RANDOMIZED STUDY OF 2 FLUOROURACIL COMBINATIONS WITH EITHERINTERFERON-ALFA-2A OR LEUCOVORIN FOR ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 13(4), 1995, pp. 921-928
Authors:
KARJA V
SYRJANEN S
KATAJA V
SYRJANEN K
Citation: V. Karja et al., C-ERBB-2 ONCOGENE EXPRESSION IN SALIVARY-GLAND TUMORS, ORL, 56(4), 1994, pp. 206-212
Authors:
KATAJA V
SYRJANEN S
YLISKOSKI M
HIPPELAINEN M
VAYRYNEN M
SAARIKOSKI S
MANTYJARVI R
JOKELA V
SALONEN JT
SYRJANEN K
Citation: V. Kataja et al., RISK-FACTORS ASSOCIATED WITH CERVICAL HUMAN PAPILLOMAVIRUS INFECTIONS- A CASE-CONTROL STUDY, American journal of epidemiology, 138(9), 1993, pp. 735-745
Risultati:
1-10
|